Article on consequences of MDR regulation within Dermatology published in JEADVNovember 29, 2021
STOCKHOLM, SWEDEN, - November 29, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today, that an article describing the consequences of the new medical device regulation (MDR) in the EU has been published in the journal "Journal of the European Academy of Dermatology and Venereology" (JEADV).
SciBase to present at the Redeye Life Science day on November 11, 2021November 5, 2021
SciBase a leading developer of augmented intelligence-based solutions for skin disorders, announced today that CFO Michael Colérus will present an update on the latest developments from SciBase at the Redeye Life Science day on November11th at 16.10 pm. The presentation will be followed by a short Q&A. The presentation will be broadcasted live and can be followed at https://www.redeye.se/events/815899/redeye-life-science-day-2021 The presentation will also be available at www.redeye.se and on the Company's website i n Redeye Universe.
The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual General Meeting in 2022:October 29, 2021
Erik Esveld (VanHerk Group)
Christer Jönsson (Fouriertransform),
Tord Lendau (Chairman of the Board).
- Load more news...